Author

Vincent Joralemon

  • Pharmaceuticals

    Can Washington State Change Pharmaceutical Advertising Forever?

    By Vincent Joralemon Pharmaceutical advertisers want health data so that they can effectively tailor the $18 billion spent annually on drug pitches to those audiences most likely to buy these products. However, a recent privacy…

    Can Washington State Change Pharmaceutical Advertising Forever?

  • FDA

    Insurance Coverage for Psychedelic Therapy

    By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. For example, experts…

    Insurance Coverage for Psychedelic Therapy

  • FDA

    The FDA Backdoor to MDMA Rescheduling

    FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.

    The FDA Backdoor to MDMA Rescheduling

    Silver Spring, MD, USA - June 25, 2022: The U.S. Department of Health and Human Services (HHS), U.S. Public Health Service (USPHS) and FDA logos are seen at the FDA headquarters, the White Oak Campus.
  • Digital Health

    Sorry, You Probably Cannot Get MDMA Through Telehealth

    Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.

    Sorry, You Probably Cannot Get MDMA Through Telehealth

    Businessman's hands typing on laptop keyboard in morning light
  • Bioethics

    Thank Ketamine for the Telehealth Extension

    The telemedicine extension is not just for psychedelics; easing these restrictions means relaxing them for other controlled substances as well.

    Thank Ketamine for the Telehealth Extension

    Doctor working with modern computer interface.
  • FDA

    Psychedelic Lobbying and Regulatory Capture

    Not all lobbying campaigns are problematic — the goal should be for regulators to leverage industry insights while maintaining independence in decision-making.

    Psychedelic Lobbying and Regulatory Capture

    Washington, D.C. skyline with highways and monuments.
  • FDA

    What Counts as a Psychedelic?

    There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.

    What Counts as a Psychedelic?

    Psychedelic drug or psychedelics hallucinogenic drugs and hallucinogens representing states of consciousness and psychology or psychological hallucinating in a 3D illustration style.
  • Clinical Research

    Ketamine Is the New Viagra

    A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.

    Ketamine Is the New Viagra

    Hundred dollar bills rolled up in a pill bottle